StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mustang Bio's enterprise value was -$12.35M on Nov 11, 2026, against -$13.98M a year earlier. Over the last 5 years it ranged from -$28.63M to $57.14M, with a median of -$6.08M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$12.35M–
2025Dec 31, 2025-$15.51M–
2024Dec 31, 2024-$410.99K-130.6%
2023Dec 29, 2023$1.34M–
2022Dec 30, 2022-$14.63M-125.6%
2021Dec 31, 2021$57.14M-70.3%
2020Dec 31, 2020$192.65M+65.1%
2019Dec 31, 2019$116.67M+62.0%
2018Dec 31, 2018$72.04M-77.7%
2017Dec 29, 2017$322.70M–

More Mustang Bio figures

See a number that looks wrong?